SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-005021
Filing Date
2022-03-02
Accepted
2022-03-02 16:30:04
Documents
17
Period of Report
2022-02-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctdh20220301_8k.htm   iXBRL 8-K 45297
2 EXHIBIT 10.1 ex_342160.htm EX-10.1 111931
3 EXHIBIT 10.2 ex_342161.htm EX-10.2 110972
4 EXHIBIT 10.3 ex_342162.htm EX-10.3 110844
5 EXHIBIT 10.4 ex_342163.htm EX-10.4 111746
  Complete submission text file 0001437749-22-005021.txt   746134

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20220228.xsd EX-101.SCH 4036
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20220228_def.xml EX-101.DEF 13508
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20220228_lab.xml EX-101.LAB 17665
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20220228_pre.xml EX-101.PRE 13475
11 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20220301_8k_htm.xml XML 4286
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

IRS No.: 593029743 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39780 | Film No.: 22704000
SIC: 2860 Industrial Organic Chemicals